September 8, 2021
September 8, 2021 – Azurity Pharmaceuticals has recalled one lot of Firvanq® (vancomycin hydrochloride for oral solution), Vancomycin 50mg/mL Kit
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Medical Insurance
September 7, 2021
September 7, 2021 – ICU Medical has issued a recall for one lot of Aminosyn II 15%, Amino Acid Injection, Sulfite Free intravenous (IV) solution to the hospital
September 1, 2021
September 1, 2021 – Invega HafyeraTM (paliperidone palmitate) extended-release injectable suspension is
now the first FDA-approved twice-yearly treatment for schizophrenia
September 1, 2021
September 1, 2021 – The U.S. FDA is requiring new and updated warnings on a class of drugs called JAK inhibitors due to an increased risk of cancer
August 31, 2021
August 31, 2021 – Keytruda® (pembrolizumab) has been U.S. FDA approved as a first-line treatment for locally advanced or metastatic urothelial carcinoma (UC)
August 30, 2021
August 30, 2021 – Due to an expanded indication granted by the U.S. FDA, Briviact® (brivaracetam) tablets, oral solution, and injection for intravenous (IV) use are now approved
August 27, 2021
August 27, 2021 – Drug manufacturer Roche is withdrawing a Tecentriq® (atezolizumab) metastatic triple
negative breast cancer (mTNBC) indication following consultation
August 27, 2021
August 27, 2021 – Teligent Pharma is recalling one lot of Lidocaine HCl Topical Solution 4%, 50mL, packaged in a screw cap glass bottle. This recall extends